Kirk Lalwani

Professor

  • 230 Citations
  • 10 h-Index
19932015

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Kirk Lalwani is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles

Research Output

A case approach to perioperative drug-drug interactions

Marcucci, C., Hutchens, M., Wittwer, E. D., Weingarten, T. N., Sprung, J., Nicholson, W. T., Lalwani, K., Metro, D. G., Dull, R. O., Swide, C., Jacob Seagull, F., Kirsch, J. & Sandson, N. B., Sep 15 2015, Springer New York. 1016 p.

Research output: Book/ReportBook

  • 1 Scopus citations

    A HAART-breaking tale: Metformin, tenofovir

    Laochamroonvorapongse, D. & Lalwani, K., Sep 15 2015, A Case Approach to Perioperative Drug-Drug Interactions. Springer New York, p. 737-740 4 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

    A needle and the damage done: Fatal forty DDI: Buprenorphine, ritonavir, CYP3A4

    Hilliard, J. & Lalwani, K., Sep 15 2015, A Case Approach to Perioperative Drug-Drug Interactions. Springer New York, p. 245-247 3 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

  • Ca va, c'est Kava: Kava, carbidopa-levodopa, dopamine receptors

    Tith, S. & Lalwani, K., Sep 15 2015, A Case Approach to Perioperative Drug-Drug Interactions. Springer New York, p. 945-947 3 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

    2 Scopus citations

    "Danshen" the night away: Fatal Forty DDI: Salvia miltiorrhiza, warfarin, CYP2C9, CYP1A2

    Carey, T. C. & Lalwani, K., Sep 15 2015, A Case Approach to Perioperative Drug-Drug Interactions. Springer New York, p. 961-964 4 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter